Ballsy Celgene Continues to Tread Carefully Into Neurosciences Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace You Might Also Like Karolinska Development AB Release: Pharma Portfolio Company Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A. January 19, 2017 Arbor Biotechnologies Comes Out of Stealth Mode March 15, 2018 Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018 January 24, 2018
Karolinska Development AB Release: Pharma Portfolio Company Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A. January 19, 2017
Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018 January 24, 2018
